Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LENZ stock hub

LENZ Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LENZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

315.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LENZ

In the news

Latest news · LENZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-33.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-23.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LENZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001815776
Company name	LENZ Therapeutics, Inc.
Country	United States
Country code	US
Cusip	52635N103
Employees	152
Employees Change	110%
Employees Change Percent	261.9
Enterprise value	$23.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-06-25
Isin	US52635N1037
Last refreshed	2026-05-10
Market cap	$315.4M
Market cap category	Small-Cap
Price	$10.06
Price currency	USD
Rev Per Employee	125,578.95x
Sector	Healthcare
Sic	2836
Symbol	LENZ
Website	https://www.lenz-tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.04%
EV Sales Forward	0.86x
EV/Sales	1.25x
FCF yield	-22.19%
P/B ratio	1.11x
P/S ratio	16.52x
PS Forward	11.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	97.81%
Gross Profit	$18.7M
Net Income	$-82.1M
Net Income Growth Years	0%
Pretax Margin	-427.62%
Profit Per Employee	$-540,309
ROA	-21.86
ROCE	-32.01
ROE	-33.63
ROIC	-23.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-60.33%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$305.9M
Cash	$292.3M
Current Assets	$301.4M
Current Liabilities	$21.2M
Debt	$815,000
Debt Equity	$0
Equity	$284.3M
Liabilities	$21.5M
Long Term Assets	$4.5M
Long Term Liabilities	$350,000
Net Cash	$291.5M
Net Cash By Market Cap	$92.43
Net Cash Growth	40.4%
Net Debt Equity	$-1.03
Tangible Book Value	$284.3M
Tangible Book Value Per Share	$9.07
WACC	13.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.23
Net Working Capital	$-11.7M
Quick ratio	13.91
Working Capital	$280.2M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-35.39%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-60.3%
200-day SMA	24.02
50-day SMA	10.33
50-day SMA vs 200-day SMA	50under200
All Time High	50.4
All Time High Change	-80.04%
All Time High Date	2025-10-02
All Time Low	8.25
All Time Low Change	21.94%
All Time Low Date	2026-03-30
ATR	0.63
Beta	1.67
Beta1y	1.92
Beta2y	1.36
Ch YTD	-37.13
High	10.1
High52	50.4
High52 Date	2025-10-02
High52ch	-80.04%
Low	9.6
Low52	8.25
Low52 Date	2026-03-30
Low52ch	21.94%
Ma50ch	-2.59%
Premarket Change Percent	1.13
Premarket Price	$9.83
Premarket Volume	1,395
Price vs 200-day SMA	-58.11%
RSI	53.76
RSI Monthly	39.18
RSI Weekly	37.01
Sharpe ratio	-0.82x
Sortino ratio	-1
Total Return	-35.39%
Tr YTD	-37.13
Tr1m	3.61%
Tr1w	13.29%
Tr3m	-29.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$38.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.08
Earnings Revenue Estimate	1,737,144x
Operating Income	$-91.1M
Operating margin	-477.5
Price target	$44
Price Target Change	$337
Price Target Change Top	$283

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,481,171%
Float Percent	58.94%
Shares Insiders	2.65%
Shares Institutions	81%
Shares Out	31,354,394
Shares Qo Q	8.87%
Shares Yo Y	35.39%
Short Float	51.28%
Short Ratio	8.13
Short Shares	30.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-82.5M
Average Volume	788,844.5x
Bv Per Share	9.07
CAPEX	$-827,000
Ch1m	3.61
Ch1w	13.29
Ch1y	-60.3
Ch3m	-29.25
Ch6m	-56.2
Change	3.5%
Change From Open	2.55
Close	9.72
Days Gap	0.93
Depreciation Amortization	287,000
Dollar Volume	6,442,424
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-91.1M
EBITDA	$-90.9M
EPS	$-2.85
F Score	1
FCF	$-70M
FCF EV Yield	-292.96x
FCF Per Share	$-2.23
Financing CF	149,745,000
Fiscal Year End	December
Founded	2,019
Income Tax	$502,000
Investing CF	-75,668,000
Ipr	-40.82
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-24
Ma150	19.22
Ma150ch	-47.65%
Ma20	9.56
Ma20ch	5.22%
Net CF	4,907,000
Next Earnings Date	2026-05-11
Open	9.81
Optionable	Yes
Position In Range	92
Post Close	10.06
Postmarket Change Percent	1.29
Postmarket Price	$10.19
Ppne	1,923,000
Pre Close	9.72
Price Date	2026-05-08
Ptbv Ratio	1.11
Relative Volume	0.81x
Revenue	19,088,000x
SBC By Revenue	65.73x
Share Based Comp	12,547,000
Tax By Revenue	2.63x
Tr6m	-56.2%
Us State	California
Volume	640,400
Z Score	22.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LENZ pay a dividend?

Capital-return profile for this ticker.

Performance

LENZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LENZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.0%

Float: +58.9% of shares outstanding

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LENZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.8

Neutral momentum band

Price vs 200-day MA

-58.1%

50/200-day relationship not available

Beta (5Y)

1.67

More volatile than the market

Sharpe ratio

-0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LENZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LENZ stock rating?

LENZ Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LENZ analysis?

The full report lives at /stocks/LENZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LENZ?

The latest report frames LENZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LENZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.